-
-
-
-
-
-
-
Enlivex CEO outlines roadmap after knee arthritis trial results
-
-
-
-
-
-
-
Enlivex Therapeutics (ENLV) Announces up to $15 Million Registered Direct Offering
-
-
-
-
-
-
-
Enlivex Announces Upcoming Virtual Investor Conference Participations
-
-
-
-
-
-
-
Enlivex Increases Previously Announced Bought Deal Offering to Approximately $46.0 Million of Ordinary Shares
-
-
-
-
-
-
-
Enlivex Therapeutics Closes $16.75 Million Registered Direct Offering
-
-
-
-
-
-
-
Enlivex Therapeutics Ltd. (ENLV) Announces Proposed 1M Share Registered Direct Offering at $8/Sh
-
-
-
-
-
-
-
ENLIVEX THERAPEUTICS TO PRESENT AT THE 2019 H.C. WAINWRIGHT GLOBAL LIFE SCIENCES CONFERENCE
21,770 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

